MHRA Drug Safety Update – February

MHRA Drug Safety Update – February

February 17, 2016

The new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 9, Issue 7, February 2016) has been published and includes articles on:

  • Valproate and of risk of abnormal pregnancy outcomes: new communication materials
  • Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia

To see the latest MHRA Drug Safety Update in full visit the MHRA website.



Posted in:


More Latest News >

Pregabalin update

Pharmacy teams may be aware of the recent patent litigation of Lyrica. The patent is now set to expire and...

PSNC Judicial Review Appeal Update

PSNC has received permission to appeal in its Judicial Review Case against the Secretary of State. On 20th October 2016, the Secretary of...